Recruiting Short Bowel Syndrome Studies in Chicago
A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD).
This is a phase 2a, multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of NST-6179 in subjects with ...
Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects
This is a randomized, double-blind, placebo-controlled, proof-of-concept (PoC), Phase 2 study to assess the safety, PK, and PD of SC administration of HM15912(sonefpeglutide) in adult subjects with SB...
About Short Bowel Syndrome Clinical Trials in Chicago
Short bowel syndrome is a condition where the body cannot absorb enough nutrients because a large portion of the small intestine is missing or damaged. It often results from surgical removal. Treatment includes specialized nutrition, medications, and sometimes intestinal transplantation.
There are currently 2 short bowel syndrome clinical trials recruiting participants in Chicago, IL. These studies are seeking a combined 54 participants. Research is being sponsored by NorthSea Therapeutics B.V., Hanmi Pharmaceutical Company Limited. Clinical trial participation is free and participants receive study-related medical care at no cost.
Short Bowel Syndrome Clinical Trials in Chicago — FAQ
Are there short bowel syndrome clinical trials in Chicago?
Yes, there are 2 short bowel syndrome clinical trials currently recruiting in Chicago, IL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Chicago?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chicago research site will contact you about next steps.
Are clinical trials in Chicago free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chicago studies also compensate for your time and travel.
What short bowel syndrome treatments are being tested?
The 2 active trials in Chicago are testing new therapies including novel drugs, biologics, and treatment approaches for short bowel syndrome.
Data updated March 2, 2026 from ClinicalTrials.gov